| Description | β-Amino Acid Imagabalin Hydrochloride is the voltage-dependent calcium channel ligand for the α2δ subunit. |
| In vivo | β-Amino Acid Imagabalin Hydrochloride had been also in phase I clinical trials for the treatment of chronic kidney disease. β-Amino Acid Imagabalin Hydrochloride had been in phase III clinical trials for the treatment of generalized anxiety disorders. |
| Synonyms | PD-0332334 |
| molecular weight | 209.71 |
| Molecular formula | C9H20ClNO2 |
| CAS | 610300-00-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Birch M, et al. A Simplified Process for the Manufacture of Imagabalin Hydrochloride (PD-0332334), an α2δ-Ligand for the Treatment of Generalised Anxiety Disorder. Org. Process Res. Dev., 2011, 15 (6), pp 1358–1364 |